Bill > HB2940

This bill directs the Oregon Health Authority (OHA) to develop a program, subject to fund availability, for providing real-time notifications in emergency departments about patients with hemoglobinopathies (genetic blood disorders like sickle cell disease). The program will help identify such patients and provide emergency staff with immediate contact information for hematologists. To develop this program, the OHA must consult with a diverse group of stakeholders, including health care providers, hospital representatives, community organizations serving patients with hemoglobinopathies, and public health organizations. The OHA is required to submit a report on its stakeholder consultations and program status to legislative health care committees by March 1, 2026, and must implement the program no later than May 1, 2026. The provisions related to stakeholder consultation will be repealed on January 2, 2027, and the bill will take effect 91 days after the 2025 legislative session adjourns. The goal is to improve emergency care and support for patients with complex blood disorders by ensuring healthcare providers have timely, specialized information.

Health and Social Services

https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB2940